Some features may not work as expected in this browser. For the full NewsNow experience, please consider updating your browser or trying a different device. Some features may not work as expected.
Please consider updating your browser or device.

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
AI
Business
Football
Sport
Entertainment
Tech
Science

Regeneron
Health
Sanofi
Disability
Diabetes
Cancer
Mental Health
Assisted Dying
Reproductive Health
Diet and Fitness
Heart Disease
Obesity
Topics

Regeneron

Share

Top Latest Popular

Experimental Regeneron antibody trevogrumab cut lean mass loss by about 42% in semaglutide users over one year

Medical Daily 5d

Easd 2026: Regeneron’s muscle preserver shows benefit at lower doses

Clinical Trials Arena 6d

Sanofi And Regeneron Rekindle Their Alliance, But Will Magic Strike Again?

Scrip Pharma Intelligence 7d

Moderna stock falls 6% in premarket: here's why

Invezz 13:19 Wed, 30 Sep

Mirum’s atebrioz, first oral approved for fop, to face Regeneron’s pasatru

Scrip Pharma Intelligence 23:23 Fri, 25 Sep

Biocon loses patent challenge bid as squires flexes discretion

Bloomberg Law 21:53 Fri, 25 Sep

Regeneron's ubamatamab, trevogrumab show strong results in Cancer and obesity studies

RTT News 7d

My Local News

Regeneron News

Latest news and updates on Regeneron Pharmaceuticals, an American biotechnology company that was founded in 1988. The company is listed on NASDAQ.

Health Health
Back to Lifestyle Health
- Diet and Fitness
- Mental Health
- Cancer Cancer
- Diabetes Diabetes
- Disability Disability
- Gastrointestinal Diseases
- Infectious Diseases
- Neurological Diseases
- Reproductive Health
- Sexual Health
- Allergies Allergies
- Alopecia Alopecia
- Antibiotic Resistance
- Assisted Dying
- Blood Disorders
- Heart Disease
- Obesity Obesity
- PTSD PTSD
- Rare Diseases
- SIDS SIDS

Regeneron Share

My Local News

Regeneron News

Regeneron

Share